Hyperbaric Oxygen Therapy Market By Application (Air Or Gas Embolism, Decompression Sickness, Infection Treatment, Wound Healing), By Product Type (Monoplace Hbot Devices, Multiplace Hbot Devices, Topical Hbot Devices), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Aug 2, 2016

Key Findings


Increasing incidences of acute and chronic wounds and growing prevalence of wound site infections has been injecting the growth in the global hyperbaric oxygen therapy market. Quickly rising patient pool in developing / emerging markets are the key opportunities available in the global market. The growing demand for the hyperbaric oxygen therapy from the emerging market is creating huge opportunity in the global market. The opportunity is majorly influenced with an increase in thepatient’s pool in the region and rising infectious diseases in the emerging countries. China and India are the two largest populated countries in the worldin Asia Pacific region. Both the countries have huge patient pool in the world. Both the countries are also attracting patients across the globe, which is injecting huge growth in the global market. There are some constraints such as high cost of hyperbaric oxygen therapy and inadequate HBOT recompense coverage,hampering the growth in the global hyperbaric oxygen therapy market. At present, hyperbaric oxygen therapy devices are very expensive. In United State, in private clinics,a single session of HBOTcost around $8 to $300, although these cost is extended to $1000 for HBOT in hospitals. Moreover, the conventional HBOT treatment is very time consuming as compared to modern or advance HBOT. Thus the high cost and time consuming has been expected to hinder the growth in the global hyperbaric oxygen therapy market during the forecasted period.


Market Segment Insight


The global hyperbaric oxygen therapy market is segmented into product type, application and geography. The application segment is segmented into air or gas embolism, decompression sickness, infection treatment, wound healing and others. Infection treatment is accounted at large share in the application segment. Whereas wound healing has been expected to grow with eye popping CAGR during the forecasted period. The growth is majorly driven by the growing prevalence of chronic and acute wounds. Moreover, growing prevalence of wound sites infections and growing popularity of leisure adventure happenings has been anticipated to inject huge demand of hyperbaric oxygen therapy devices and increase usage among various application. The product type segment is segmented into monoplace HBOT devices, multiplace HBOT devices and topical HBOT devices. Monoplace HBOT devices holds the largest market share in the product type segment, and expected to grow with high CAGR during the forecasted period of 2016-2022.


Regional Insight


Globally, the hyperbaric oxygen therapy market is segmented intoNorth America, Europe, APAC and ROW. North American holds the largest market share in the global hyperbaric oxygen therapy market followed by Europe.In 2014, North America holds around 32% of global hyperbaric oxygen therapy market. The dominance of the region is mainly driven by the growing prevalence of acute and chronic wound and presence of some big key players who are investing a huge amount for the development of advance therapy to enhance the effectiveness of the therapy in the region. Europe market holds the second largest market share in the global market. The market share in the European region is boosted by the growing demand for hyperbaric oxygen therapy in the regional market due to rising leisure adventure activities. Increasing incidences of acute and chronic wounds and growing prevalence of wound site infections is increasing the growth in the European market. However, Asia Pacific market has been expected to grow with eye popping CAGR during the forecasted period 2016-2022. The growth in Asia Pacific region is majorly driven by the rising prevalence of acute and chronic wound in the region. Moreover, the rising prevalence of wound site infection has beenanticipated to boost the growth in the hyperbaric oxygen therapy market in Asia Pacific region. The growing patient pool in the Asia Pacific countries such as China, India and others is also injecting positive growth opportunity to develop the regional hyperbaric oxygen treatment market. ROW region has been expected to grow at stagnant rate in the global market.


Competitive Insights


Some of the keymarket playersare Advanced Hyperbaric Recovery, ETC BioMedical Systems, Fink Engineering Pty. Ltd., Hearmec Co., Ltd., Hyperbaric SAC, IHC Hytech B.V., Life healthcare, Richmond Hyperbaric Health Center, Sechrist Industries, Inc. and SOS Medical Group Ltd. (SOS Hyperlite Ltd).Mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.

CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11


CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET SUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET OUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET VALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12


CHAP 3. GLOBAL HYPERBARIC OXYGEN THERAPY 13
3.1. MARKET DRIVER ANALYSIS 13
3.1.1. INCREASING INCIDENCES OF ACUTE AND CHRONIC WOUNDS 13
3.1.2. GROWING PREVALENCE OF WOUND SITE INFECTIONS 13
3.1.3. RISING LEISURE ADVENTURE ACTIVITIES 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.2.1. INADEQUATE HBOT RECOMPENSE COVERAGE 13
3.3. KEY OPPORTUNITIES 13
3.3.1. QUICKLY RISING PATIENT POOL IN DEVELOPING / EMERGING MARKETS 13
3.4. CHALLENGES 13
3.4.1. HIGH COST OF HYPERBARIC OXYGEN THERAPY 13


CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET– PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET– PESTEL ANALYSIS 14
4.3. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET– GAP ANALYSIS 14


CHAP 5. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET BY APPLICATION 2012-2022 ($ MILLION) 15
5.1. GLOBAL AIR OR GAS EMBOLISM MARKET 2012-2022 ($ MILLION) 15
5.2. GLOBAL DECOMPRESSION SICKNESS MARKET 2012-2022 ($ MILLION) 15
5.3. GLOBAL INFECTION TREATMENT MARKET 2012-2022 ($ MILLION) 15
5.4. GLOBAL WOUND HEALING MARKET 2012-2022 ($ MILLION) 15
5.5. GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 15


CHAP 6. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET BY PRODUCT TYPE 2012-2022 ($ MILLION) 16
6.1. GLOBAL MONOPLACE HBOT DEVICES MARKET 2012-2022 ($ MILLION) 16
6.2. GLOBAL MULTIPLACE HBOT DEVICES MARKET 2012-2022 ($ MILLION) 16
6.3. GLOBAL TOPICAL HBOT DEVICES MARKET 2012-2022 ($ MILLION) 16


CHAP 7. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 17
7.1. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET BY REGION 2012-2022 ($ MILLION) 17
7.2. NORTH AMERICA 17
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 17
7.2.3.1. U.S. 17
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.2.3.2. CANADA 17
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.3. EUROPE 17
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 17
7.3.3.1. GERMANY 17
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.2. UK 18
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.3. FRANCE 18
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.4. RUSSIA 18
7.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.5. REST OF EUROPE 18
7.3.3.5.1. ROE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 19
7.3.3.5.2. ROE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 19
7.4. ASIA PACIFIC 19
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
7.4.3.1. CHINA 19
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.4.3.2. INDIA 19
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.4.3.3. JAPAN 19
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 19
7.4.3.4. ROAPAC 19
7.4.3.4.1. ROAPAC MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 20
7.4.3.4.2. ROAPAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 20
7.5. REST OF THE WORLD 20
7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
7.5.3.1. LATIN AMERICA 20
7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.5.3.2. MIDDLE EAST AND AFRICA 20
7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20


CHAP 8. COMPETITIVE LANDSCAPE 21
8.1. ADVANCED HYPERBARIC RECOVERY 22
8.1.1. COMPANY OVERVIEW 22
8.1.2. SCOT ANALYSIS 22
8.1.3. PRODUCT BENCHMARKING 22
8.1.4. STRATEGIC INITIATIVES 22
8.2. ETC BIOMEDICAL SYSTEMS 22
8.2.1. COMPANY OVERVIEW 22
8.2.2. SCOT ANALYSIS 22
8.2.3. PRODUCT BENCHMARKING 22
8.2.4. STRATEGIC INITIATIVES 22
8.3. FINK ENGINEERING PTY. LTD. 22
8.3.1. COMPANY OVERVIEW 22
8.3.2. SCOT ANALYSIS 22
8.3.3. PRODUCT BENCHMARKING 22
8.3.4. STRATEGIC INITIATIVES 22
8.4. GULF COAST HYPERBARICS, INC. 22
8.4.1. COMPANY OVERVIEW 22
8.4.2. SCOT ANALYSIS 22
8.4.3. PRODUCT BENCHMARKING 22
8.4.4. STRATEGIC INITIATIVES 22
8.5. HAUX-LIFE-SUPPORT GMBH 22
8.5.1. COMPANY OVERVIEW 22
8.5.2. SCOT ANALYSIS 22
8.5.3. PRODUCT BENCHMARKING 22
8.5.4. STRATEGIC INITIATIVES 22
8.6. HEALOGICS 22
8.6.1. COMPANY OVERVIEW 22
8.6.2. SCOT ANALYSIS 23
8.6.3. PRODUCT BENCHMARKING 23
8.6.4. STRATEGIC INITIATIVES 23
8.7. HEARMEC CO., LTD. 23
8.7.1. COMPANY OVERVIEW 23
8.7.2. SCOT ANALYSIS 23
8.7.3. PRODUCT BENCHMARKING 23
8.7.4. STRATEGIC INITIATIVES 23
8.8. HYPERBARIC SAC 23
8.8.1. COMPANY OVERVIEW 23
8.8.2. SCOT ANALYSIS 23
8.8.3. PRODUCT BENCHMARKING 23
8.8.4. STRATEGIC INITIATIVES 23
8.9. IHC HYTECH B.V. 23
8.9.1. COMPANY OVERVIEW 23
8.9.2. SCOT ANALYSIS 23
8.9.3. PRODUCT BENCHMARKING 23
8.9.4. STRATEGIC INITIATIVES 23
8.10. LIFE HEALTHCARE 23
8.10.1. COMPANY OVERVIEW 23
8.10.2. SCOT ANALYSIS 23
8.10.3. PRODUCT BENCHMARKING 23
8.10.4. STRATEGIC INITIATIVES 23
8.11. OXYHEAL HEALTH GROUP 23
8.11.1. COMPANY OVERVIEW 23
8.11.2. SCOT ANALYSIS 23
8.11.3. PRODUCT BENCHMARKING 23
8.11.4. STRATEGIC INITIATIVES 23
8.12. PERRY BAROMEDICAL 24
8.12.1. COMPANY OVERVIEW 24
8.12.2. SCOT ANALYSIS 24
8.12.3. PRODUCT BENCHMARKING 24
8.12.4. STRATEGIC INITIATIVES 24
8.13. RICHMOND HYPERBARIC HEALTH CENTER 24
8.13.1. COMPANY OVERVIEW 24
8.13.2. SCOT ANALYSIS 24
8.13.3. PRODUCT BENCHMARKING 24
8.13.4. STRATEGIC INITIATIVES 24
8.14. SECHRIST INDUSTRIES, INC. 24
8.14.1. COMPANY OVERVIEW 24
8.14.2. SCOT ANALYSIS 24
8.14.3. PRODUCT BENCHMARKING 24
8.14.4. STRATEGIC INITIATIVES 24
8.15. SOS MEDICAL GROUP LTD. 24
8.15.1. COMPANY OVERVIEW 24
8.15.2. SCOT ANALYSIS 24
8.15.3. PRODUCT BENCHMARKING 24
8.15.4. STRATEGIC INITIATIVES 24

TABLE 1 GLOBAL HYPERBARIC OXYGEN THERAPY MARKET BY APPLICATION 2012-2022 ($ MILLION) 24
TABLE 2 GLOBAL AIR OR GAS EMBOLISM MARKET 2012-2022 ($ MILLION) 24
TABLE 3 GLOBAL DECOMPRESSION SICKNESS MARKET 2012-2022 ($ MILLION) 24
TABLE 4 GLOBAL INFECTION TREATMENT MARKET 2012-2022 ($ MILLION) 25
TABLE 5 GLOBAL WOUND HEALING MARKET 2012-2022 ($ MILLION) 25
TABLE 6 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 25
TABLE 7 GLOBAL HYPERBARIC OXYGEN THERAPY MARKET BY PRODUCT TYPE 2012-2022 ($ MILLION) 25
TABLE 8 GLOBAL MONOPLACE HBOT DEVICES MARKET 2012-2022 ($ MILLION) 25
TABLE 9 GLOBAL MULTIPLACE HBOT DEVICES MARKET 2012-2022 ($ MILLION) 25
TABLE 10 GLOBAL TOPICAL HBOT DEVICES MARKET 2012-2022 ($ MILLION) 25
TABLE 11 NORTH AMERICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
TABLE 12 NORTH AMERICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 13 NORTH AMERICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 25
TABLE 14 U.S. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
TABLE 15 U.S. GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 16 CANADA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
TABLE 17 CANADA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ MILLION) 25
TABLE 18 CANADA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 19 EUROPE GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
TABLE 20 EUROPE GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 21 EUROPE GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 25
TABLE 22 GERMANY GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 23 GERMANY METABOLOMICS TECHNOLOGY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 24 UK GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 25 UK GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 26 ASIA PACIFIC GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 27 ASIA PACIFIC GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 28 ASIA PACIFIC GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 26
TABLE 29 CHINA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 30 CHINA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 31 INDIA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 32 INDIA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 33 JAPAN GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 34 JAPAN GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 35 MIDDLE EAST & AFRICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 36 MIDDLE EAST & AFRICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 37 LATIN AMERICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 38 LATIN AMERICA GLOBAL HYPERBARIC OXYGEN THERAPY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26

FIGURE 1 MARKET SHARE BY REGIONS 27
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 13 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 14 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)